Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 43 Records) |
Query Trace: Atherosclerosis and PCSK9[original query] |
---|
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis.
The Journal of clinical investigation 2022 10 132 (24): . Hindy George, Tyrrell Daniel J, Vasbinder Alexi, Wei Changli, Presswalla Feriel, Wang Hui, Blakely Pennelope, Ozel Ayse Bilge, Graham Sarah, Holton Grace H, Dowsett Joseph, Fahed Akl C, Amadi Kingsley-Michael, Erne Grace K, Tekmulla Annika, Ismail Anis, Launius Christopher, Sotoodehnia Nona, Pankow James S, Thørner Lise Wegner, Erikstrup Christian, Pedersen Ole Birger, Banasik Karina, Brunak Søren, Ullum Henrik, Eugen-Olsen Jesper, Ostrowski Sisse Rye, , Haas Mary E, Nielsen Jonas B, Lotta Luca A, , Engström Gunnar, Melander Olle, Orho-Melander Marju, Zhao Lili, Murthy Venkatesh L, Pinsky David J, Willer Cristen J, Heckbert Susan R, Reiser Jochen, Goldstein Daniel R, Desch Karl C, Hayek Salim |
Ethnic differences in the association between lipid metabolism genes and lipid levels in black and white South African women. Atherosclerosis 2015 Jun 240 (2): 311-7. Ellman Nicole, Keswell Dheshnie, Collins Malcolm, Tootla Mehreen, Goedecke Julia |
The Influence of OLR1 and PCSK9 Gene Polymorphisms on Ischemic Stroke: Evidence from a Meta-Analysis. Scientific reports 2015 5 18224. Au Anthony, Griffiths Lyn R, Cheng Kian-Kai, Wee Kooi Cheah, Irene Looi, Keat Wei L |
Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases. Science (New York, N.Y.) 2016 Aug 353 (6301): 827-30. Franzén Oscar, Ermel Raili, Cohain Ariella, Akers Nicholas K, Di Narzo Antonio, Talukdar Husain A, Foroughi-Asl Hassan, Giambartolomei Claudia, Fullard John F, Sukhavasi Katyayani, Köks Sulev, Gan Li-Ming, Giannarelli Chiara, Kovacic Jason C, Betsholtz Christer, Losic Bojan, Michoel Tom, Hao Ke, Roussos Panos, Skogsberg Josefin, Ruusalepp Arno, Schadt Eric E, Björkegren Johan L |
LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers. PloS one 2016 11 (1): e0146990. Ochoa Eguzkine, Iriondo Mikel, Manzano Carmen, Fullaondo Asier, Villar Irama, Ruiz-Irastorza Guillermo, Zubiaga Ana M, Estonba Ando |
Autosomal recessive hypercholesterolemia in Spain. Atherosclerosis 2017 12 269 1-5. Sánchez-Hernández Rosa María, Prieto-Matos Pablo, Civeira Fernando, Lafuente Eduardo Esteve, Vargas Manuel Frías, Real José T, Goicoechea Fernando Goñi, Fuentes Francisco J, Pocovi Miguel, Boronat Mauro, Wägner Ana María, Masana Lu |
Evaluation of PCSK9 levels and its genetic polymorphisms in women with polycystic ovary syndrome. Gene 2017 Nov . Xavier Luana B, Sóter Mirelle O, Sales Mariana F, Oliveira Daisy K, Reis Helton J, Candido Ana L, Reis Fernando M, Silva Ieda O, Gomes Karina B, Ferreira Cláudia |
R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction. Journal of clinical lipidology 2018 Apr . Mostaza Jose M, Lahoz Carlos, Salinero-Fort Miguel A, de Dios Olaya, Castillo Elisa, González-Alegre Teresa, García-Iglesias Francisca, Estirado Eva, Laguna Fernando, Sabín Concesa, López Silvia, Cornejo Victor, de Burgos Carmen, Sanchez Vanesa, Garcés Carmen, |
Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobank. EBioMedicine 2019 7 45 487-494. Wang Qi, Wang Yunzhang, Lehto Kelli, Pedersen Nancy L, Williams Dylan M, Hägg Sa |
ANGPTL3 Mutations in Unrelated Chinese Han Patients with Familial Hypercholesterolemia. Current pharmaceutical design 2019 3 25 (2): 190-200. Yang Yunyun, Yang Song, Jiao Xiaolu, Li Juan, Zhu Miaomiao, Wang Luya, Qin Yanw |
Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management. Progress in cardiovascular diseases 2019 11 62 (5): 414-422. Miname Marcio H, Santos Raul |
A systematic review of LDLR, PCSK9, and APOB variants in Asia. Atherosclerosis 2020 7 305 50-57. Mahdieh Nejat, Heshmatzad Katayoun, Rabbani Bahar |
PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle-Aged Population: The STANISLAS Cohort. Journal of the American Heart Association 2020 Apr 9 (7): e014758. Ferreira João Pedro, Xhaard Constance, Lamiral Zohra, Borges-Canha Marta, Neves João Sérgio, Dandine-Roulland Claire, LeFloch Edith, Deleuze Jean-François, Bacq-Daian Delphine, Bozec Erwan, Girerd Nicolas, Boivin Jean-Marc, Zannad Faiez, Rossignol Patri |
High-Sensitivity C-Reactive Protein and Carotid Intima Media Thickness as Markers of Subclinical Inflammation and Atherosclerosis in Pediatric Patients with Hypercholesterolemia. Molecules (Basel, Switzerland) 2020 11 25 (21): . Blinc Lana, Mlinaric Matej, Battelino Tadej, Groselj U |
PCSK9 post-transcriptional regulation: Role of a 3'UTR microRNA-binding site variant in linkage disequilibrium with c.1420G. Atherosclerosis 2020 11 314 63-70. Decourt Charlotte, Janin Alexandre, Moindrot Marine, Chatron Nicolas, Nony Séverine, Muntaner Manon, Dumont Sabrina, Divry Eléonore, Dauchet Luc, Meirhaeghe Aline, Marmontel Oriane, Bardel Claire, Charrière Sybil, Cariou Bertrand, Moulin Philippe, Di Filippo Mathil |
PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis. Frontiers in genetics 2020 11 11 1020. Guo Qianyun, Feng Xunxun, Zhou Yuj |
Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J. Journal of atherosclerosis and thrombosis 2021 9 29 (8): 1201-1212. Harada-Shiba Mariko, Ako Junya, Hirayama Atsushi, Nakamura Masato, Nohara Atsushi, Sato Kayoko, Murakami Yoshitaka, Koshida Ryusuke, Ozaki Asuka, Arai Hideno |
Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation. Atherosclerosis 2021 8 349 211-218. Marco-Benedí Victoria, Cenarro Ana, Laclaustra Martín, Larrea-Sebal Asier, Jarauta Estíbaliz, Lamiquiz-Moneo Itziar, Calmarza Pilar, Bea Ana M, Plana Núria, Pintó Xavier, Martín César, Civeira Fernan |
Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland. Arteriosclerosis, thrombosis, and vascular biology 2021 8 41 (10): 2616-2628. Björnsson Eythór, Thorgeirsson Guðmundur, Helgadóttir Anna, Thorleifsson Guðmar, Sveinbjörnsson Garðar, Kristmundsdóttir Snaedís, Jónsson Hákon, Jónasdóttir Aðalbjörg, Jónasdóttir Áslaug, Sigurðsson Ásgeir, Guðnason Thórarinn, Ólafsson Ísleifur, Sigurðsson Emil L, Sigurðardóttir Ólöf, Viðarsson Brynjar, Baldvinsson Magnús, Bjarnason Ragnar, Danielsen Ragnar, Matthíasson Stefán E, Thórarinsson Björn L, Grétarsdóttir Sólveig, Steinthórsdóttir Valgerður, Halldórsson Bjarni V, Andersen Karl, Arnar Davíð O, Jónsdóttir Ingileif, Guðbjartsson Daníel F, Hólm Hilma, Thorsteinsdóttir Unnur, Sulem Patrick, Stefánsson Ká |
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors. Cardiovascular research 2021 7 118 (9): 2103-2111. Blanchard Valentin, Chemello Kévin, Hollstein Tim, Hong-Fong Clément Chong, Schumann Friederike, Grenkowitz Thomas, Nativel Brice, Coassin Stefan, Croyal Mikaël, Kassner Ursula, Lamina Claudia, Steinhagen-Thiessen Elisabeth, Lambert Gill |
Variants of PCSK9 Gene Are Associated with Subclinical Atherosclerosis and Cardiometabolic Parameters in Mexicans. The GEA Project. Diagnostics (Basel, Switzerland) 2021 4 11 (5): . Zamarrón-Licona Erasmo, Rodríguez-Pérez José Manuel, Posadas-Sánchez Rosalinda, Vargas-Alarcón Gilberto, Baños-González Manuel Alfonso, Borgonio-Cuadra Verónica Marusa, Pérez-Hernández Nonanz |
[TREATMENT OF HOMOZYGOTES OF FAMILIAL HYPERCHOLESTEROLEMIA: RECOMMENDATIONS OF THE ISRAELI SOCIETY OF ATHEROSCLEROSIS]. Harefuah 2021 3 160 (3): 170-174. Cohen Hofit, Durst Ronen, Elis Avishay, Gavish Dov, Schurr Dani |
The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels. Journal of cardiovascular development and disease 2022 5 9 (5): . Levstek Tina, Podkrajšek Nik, Rehberger Likozar Andreja, Šebeštjen Miran, Trebušak Podkrajšek Katari |
Increased Carotid Intima-Media Thickness in Asymptomatic Individuals Is Associated with the PCSK9 (rs2149041) Gene Polymorphism in the Mexican Mestizo Population: Results of the GEA Cohort. Life (Basel, Switzerland) 2022 10 12 (10): . Posadas-Sánchez Rosalinda, Vargas-Alarcón Gilberto, Pérez-Méndez Óscar, Pérez-Hernández Nonanzit, Rodríguez-Pérez José Manu |
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study. Nutrition, metabolism, and cardiovascular diseases : NMCD 2022 1 32 (3): 684-691. Iannuzzo Gabriella, Buonaiuto Alessio, Calcaterra Ilenia, Gentile Marco, Forte Francesco, Tripaldella Maria, Di Taranto Maria D, Giacobbe Carola, Fortunato Giuliana, Rubba Paolo O, Di Minno Matteo N Dar |
Amplified Risk of Intracranial Artery Stenosis/Occlusion Associated With RNF213 p.R4810K in Familial Hypercholesterolemia. JACC. Asia 2023 8 3 (4): 625-633. Kotaro Noda, Yorito Hattori, Mika Hori, Yuriko Nakaoku, Akito Tanaka, Takeshi Yoshimoto, Kunihiro Nishimura, Takanori Yokota, Mariko Harada-Shiba, Masafumi Iha |
Correlations of PCSK9 and LDLR gene polymorphisms as well as serum PCSK9 levels with atherosclerosis and lipid metabolism in maintenance hemodialysis patients. Journal of clinical pharmacology 2023 8 . Jun Cui, Yuxiang Qiu, Ningsu Kang, Jianxun Lu, Lu Zhe |
Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia. Circulation. Genomic and precision medicine 2023 3 e003887. Chaudhry Ahsen, Trinder Mark, Vesely Kristin, Cermakova Lubomira, Jackson Linda, Wang Jian, Hegele Robert A, Brunham Liam |
Genetic backgrounds and diagnosis of familial hypercholesterolemia. Clinical genetics 2023 10 . Joanna Rogozik, Renata G?ówczy?ska, Marcin Grabows |
Novel protein-truncating variant in the APOB gene may protect from coronary artery disease and adverse cardiovascular events. Atherosclerosis plus 2023 1 49 42-46. Mango Gabriele, Osti Nicola, Udali Silvia, Vareschi Anna, Malerba Giovanni, Giorgetti Alejandro, Pizzolo Francesca, Friso Simonetta, Girelli Domenico, Olivieri Oliviero, Castagna Annalisa, Martinelli Nico |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: